Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on June 29, 2026

Jun. 29, 2026

DueTrace Launches the World's First 'Mutual Consent' Debt Tracker to End Awkward IOUs

Indeterminate EIN Presswire

Jun. 29, 2026

TRUE Addiction & Behavioral Health Introduces New Research Designed to Transform Addiction and Mental Health Treatment

Indeterminate EIN Presswire

Jun. 29, 2026

Island Passage Accelerates toward Drilling at the EL02 Project Bougainville Island, Papua New Guinea

Indeterminate GlobeNewswire

Jun. 29, 2026

Mohamed Rabie Moawad: AI Drives Letsia’s Next Growth Phase After WMF 2026

Indeterminate EIN Presswire

Jun. 29, 2026

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

Indeterminate GlobeNewswire

Jun. 29, 2026

Mohamed Rabie Moawad:Letsia’s Digital Infrastructure Investments Exceed SAR 50 Million Through HyperDC in Riyadh

Indeterminate EIN Presswire

Jun. 29, 2026

ESET takes part in global Operation Endgame to disrupt Amadey botnet and Stealc infostealer

Indeterminate EIN Presswire

Jun. 29, 2026

Fortuna delivers robust Feasibility Study for the Diamba Sud Gold Project in Senegal: After-tax IRR of 60% and NPV5% of US$1 billion using US$3,500/oz

Indeterminate GlobeNewswire

Jun. 29, 2026

Tilray Brands Strengthens Global Medical Cannabis Platform and Canadian Patient Access Through HelloMD Acquisition

Indeterminate GlobeNewswire

Jun. 29, 2026

Praxis Precision Medicines Announces Extension Period for Relutrigine for Treatment of SCN2A and SCN8A Developmental and Epileptic Encephalopathies

Indeterminate GlobeNewswire

Jun. 29, 2026

Beach Day API Launches Real-Time Beach and Ocean Data API for Developers

Indeterminate GlobeNewswire

Jun. 29, 2026

Elevra Lithium Breaks Ground on Fully Funded North American Lithium Expansion

Indeterminate GlobeNewswire

Jun. 29, 2026

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

Jun. 29, 2026

Mondia Strengthens Gaming Offering with Ubisoft+ Partnership

Indeterminate EIN Presswire

Jun. 29, 2026

Dragon Pharma Store Announces Expansion of Research Product Catalog with Addition of KLOW 80mg

Indeterminate GlobeNewswire

Jun. 29, 2026

Digital Realty Announces Secondary Offering of Common Stock by Blackstone

Indeterminate GlobeNewswire

Jun. 29, 2026

Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory Ulcerative Colitis Patients and Strengthening the Phase 3 Maintenance Safety Database

Indeterminate GlobeNewswire

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire

Jun. 29, 2026

Gain Therapeutics Receives FDA Clearance of IND to Advance GT-02287 into Phase 2 Clinical Development for Parkinson’s Disease

Indeterminate GlobeNewswire